Authors

Carol Tringali, MS, RN

Latest:

Carol Tringali on Closing the Gaps in Psychosocial Care

Carolina Moreno Atanasio, MD

Latest:

Dr. Atanasio on Ibrutinib and Obinuzutumab Combination in CLL/SLL

Carolina Moreno Atanasio, MD, University of Barcelona, discusses an ongoing phase III study comparing ibrutinib and obinutuzumab with chlorambucil and obinutuzumab in treatment-naÃ¯ve patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

Caroline Robert, MD, PhD

Caroline Robert, MD, PhD, is the head of the Dermatology Unit at Gustave Roussy.

Latest:

Dr Robert on the Role of Adjuvant Anti–PD-1 Therapy in Resected Stage IIB/C Melanoma

Caroline Robert, MD, PhD, discusses the role of adjuvant anti–PD-1 therapy in resected stage IIB/IIC melanoma based on findings from the KEYNOTE-716 and CheckMate 76K trials.

Caroline Seymour

Managing Editor,

Latest:

Toxicity Considerations Drive Treatment Strategies in the New Era of NSCLC Therapy

Balazs Halmos, MD, MS, and Jamie E. Chaft, MD, discuss how safety considerations contribute to treatment selection in NSCLC.

Carolyn D. Britten, MD

Latest:

Dr. Carolyn Britten on Next Steps in Immunotherapy

Carolyn D. Britten, MD, chief, Division of Hematology Oncology, associate director, Clinical Investigations, at the Hollings Cancer Center, Medical University of South Carolina, discusses questions that remain in immunotherapy.

Carolyn Lefkowits, MD

Latest:

Dr. Lefkowits Addresses Misconceptions About Palliative Care Integration

Carolyn Lefkowits, MD, gynecologic oncologist, and palliative care doctor, at the University of Colorado, addresses common misconceptions regarding palliative care integration.

Carolyn Owen, MD, University of Calgary

Caron Jacobson, MD

Latest:

The Future of CAR T-Cell Therapy in LBCL

Caron A. Jacobson, MD, and Miguel-Angel Perales, MD, look at both the regulatory and clinical components that will shape future research and utilization of CAR T-cell therapy in oncology and beyond.

Caron Jacobson, MD, Harvard Medical School

Carrie L. Langstraat, MD

Latest:

Dr. Langstraat on Sentinel Lymph Nodes for Endometrial Cancer

Carrie L. Langstraat, MD, gynecologic oncologist, Mayo Clinic, discusses the role of sentinel lymph nodes in patients with endometrial cancers.

Carrie Stricker, PhD, RN

Latest:

Carrie Stricker on the Efficacy of Survivorship Care Plans

Carrie Stricker from the Abramson Cancer Center of the University of Pennsylvania on the Efficacy of Survivorship Care Plans for Posttreatment Breast Cancer Survivors.

Carryn Anderson, MD

Latest:

Dr. Anderson on Superoxide Dismutase Mimetic GC4419 in Treating Patients With Oropharyngeal Carcinoma

Carryn Anderson, MD, assistant professor of Radiation Oncology, University of Iowa, discusses a phase Ib/IIa study of superoxide dismutase mimetic GC4419 to reduce chemoradiotherapy-induced oral mucositis in patients with oral cavitiy or oropharyngeal carcinoma.

Cary Presant, MD, FACP, FASCO

Latest:

Dr. Presant on Adjusting Clinical Trials to Value-Based Care

Cary Presant, MD, FACP, FASCO, City of Hope Medical Center, discusses clinical trials and value-based care.

Casey Cosgrove, MD

Latest:

Dr Cosgrove on the Evolution of ADC Treatment in Ovarian Cancer

Casey M. Cosgrove, MD, discusses the evolution of treatment with antibody-drug conjugates for patients with ovarian cancer.

Casey M. Cosgrove, MD

Latest:

Dr. Cosgrove on Utilizing Biomarker-Informed Treatments Endometrial Cancer

Casey M. Cosgrove, MD, discusses utilizing biomarker-informed treatments in endometrial cancer.

Casey Moffa, DO

Latest:

How to Perform the Perfect Bone Marrow Biopsy

Obtaining a high-quality bone marrow aspirate and biopsy is very important for the patientâ€”and for you. Following these general guidelines will help you do this successfully.

Catherine Bollard, MD

Latest:

Dr. Bollard on the Treatment of EBV-Positive Lymphoma

Catherine Bollard, MBChB, MD, Professor of Pediatrics, Medicine, and Pathology & Immunology, Baylor College of Medicine, discusses the treatment of EBV-positive lymphoma with T-cell therapy.

Catherine Frenette, MD, FAST, AGAF, Scripps MD Anderson Cancer Center

Catherine Frenette, MD, Scripps Green Hospital

Catherine Lyons, RN, MS

Latest:

Merging Community Practices With an Academic Cancer Center

Consolidation of community oncology practices with hospital-based cancer centers is an accelerating trend that will affect future healthcare delivery models. This year, the Community Oncology Alliance reported hospital acquisitions and corporate mergers among 55% of 1338 community oncology practices surveyed, representing a 20% increase over the previous year's results.